EDITAS MEDICINE, INC. Operating Loss Carryforwards
EDITAS MEDICINE, INC. (EDIT) had Operating Loss Carryforwards of $147.80 million as of 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2019-03-01
- 2018-12-31: Operating Loss Carryforwards $147.80M.
- 2017-12-31: Operating Loss Carryforwards $202.70M.
- 2016-12-31: Operating Loss Carryforwards $82.40M.
- 2015-12-31: Operating Loss Carryforwards $58.30M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2018-12-31 | $147.80M 10-K · filed 2019-03-01 |
| 2017-12-31 | $202.70M 10-K · filed 2019-03-01 |
| 2016-12-31 | $82.40M 10-K · filed 2018-03-08 |
| 2015-12-31 | $58.30M 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |